1. Type 2 diabetes accounts for 90-95% of diabetes cases worldwide.
2. Early use of SGLT2 inhibitors and GLP-1 receptor agonists is recommended for high-risk individuals. 
3. Regular screening is crucial as most patients are asymptomatic.
4. Lifestyle modifications and weight loss are critical treatment goals.
5. Continuous glucose monitoring offers significant benefits in glycemic control.
6. Tailored treatment plans are essential for reducing complications and improving outcomes.

Source: JAMA